Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
Jan‐Niklas Eckardt(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Jan Moritz Middeke(Fresenius (Germany)), Cristina Sauerland(University of Münster), Karsten Spiekermann(German Cancer Research Center), Sebastian Stasik, Utz Krug(Klinikum Leverkusen), Wolfgang E. Berdel(University Hospital Münster), Karsten Wendt, Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Klaus H. Metzeler(University Hospital Leipzig), Carsten Müller‐Tidow(Heidelberg University), Wolfgang Hiddemann(The University of Texas MD Anderson Cancer Center), Claudia D. Baldus(University Hospital Schleswig-Holstein), Dennis Görlich(University of Münster), Friedrich Stölzel(German Cancer Research Center), Julia-Annabell Georgi(University Hospital Carl Gustav Carus), Peter Heisig(Institute of Software), Jiřı́ Mayer(Masaryk University), Mathias Hänel(Klinikum Chemnitz), Christoph Schliemann(University Hospital Münster), Jan Braess, Frank Kroschinsky(University Hospital Carl Gustav Carus), Maher Hanoun(Essen University Hospital), Uwe Platzbecker(National Center for Tumor Diseases), Stefan W. Krause(Universitätsklinikum Erlangen), Tobias Herold(German Cancer Research Center), Hubert Serve(Goethe University Frankfurt), Martin Kaufmann(Robert Bosch Hospital), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Johannes Schetelig(University Hospital Carl Gustav Carus), Bernhard J. Woermann(Charité - Universitätsmedizin Berlin), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 18
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k